1-(4-biphenyl-1-yl)-3-(dimethylamino)-1-propanone hydrochloride | 5409-63-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(4-biphenyl-1-yl)-3-(dimethylamino)-1-propanone hydrochloride
• 英文别名: Dimethyl-[3-oxo-3-(4-phenylphenyl)propyl]azanium;chloride
• CAS: 5409-63-2
• 化学式: C₁₇H₁₉NO*ClH
• 分子量: 289.805
• InChiKey: ZLBBNTLIRYOJMR-UHFFFAOYSA-N

物化性质

• 熔点：
  176-177 °C

计算性质

• 辛醇/水分配系数(LogP)：
  3.91
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  20.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-biphenyl-1-yl)-3-(dimethylamino)-1-propanone hydrochloride 在 乙酸酐 作用下， 以 乙醇 、 水 为溶剂， 反应 17.5h， 生成 1-[2-(Biphenyl-4-carbonyl)-allyl]-1H-pyridin-2-one
  参考文献：
  名称：

  Synthesis and antifungal activity of a series of novel 1,2-disubstituted propenones

  摘要：

  To find an antifungal agent other than those of the imidazole and triazole series, a new class of 1,2-disubstituted propenones I and II was prepared and tested for antifungal activity. Comparison of the structure-activity relationships showed that the conjugated structure of carbonyl and exomethylene groups in I and II plays an important role in potent antifungal activity. However, it is noteworthy that compounds 53, 54, and 56, which have a hydroxymethyl or methoxymethyl group instead of an exo-methylene group in I, also showed potent activity. Although many compounds exhibited strong antifungal activity in vitro, none showed activity in vivo of oral efficacy against subacute systemic candidiasis in mice.

  DOI：

  10.1021/jm00391a037
• 作为产物：
  描述：

  联苯单乙酮 、 盐酸二甲胺 在 盐酸 、 paraformaldehyde 作用下， 以 异戊醇 、 丙酮 为溶剂， 生成 1-(4-biphenyl-1-yl)-3-(dimethylamino)-1-propanone hydrochloride
  参考文献：
  名称：

  THERAPEUTIC AGENT FOR DIABETES

  摘要：

  用于治疗糖尿病的疗法剂，包括公式[I]的化合物 其中 X是公式的组 其中R4和R5相同或不同，每个都是氢原子，可选地取代的具有1至5个碳原子的烷基等等，R6是氢原子或氨基保护基团；R1是具有1至5个碳原子的可选取代烷基，具有2至6个碳原子的可选取代烯基等等，R2是氢原子，具有1至5个碳原子的可选取代烷基等等，R2'是氢原子，R3是具有1至5个碳原子的可选取代烷基等等，其前药，药用可接受盐，水合物和溶剂化物。 本发明的化合物在血糖升高状态下表现出优越的降血糖作用，但在正常范围或低血糖状态下不影响血糖，这意味着它没有低血糖等严重副作用。因此，本发明的化合物作为治疗糖尿病的药物很有用，也用作预防糖尿病慢性并发症。

  公开号：

  EP0885869A1

文献信息

• N-Alkylation of benzimidazoles with ketonic Mannich bases and the reduction of the resulting 1-(3-oxopropyl)benzimidazoles
  作者：Gheorghe Roman

  DOI：10.2478/s11532-012-0062-x

  日期：2012.10.1

  position 2, and 5,6-dimethylbenzimidazole have been alkylated at N 1 with ketonic Mannich bases derived from acetophenones, acetylnaphthalenes, 2-acetylthiophene and 1-tetralone to afford a series of novel 1-(3-oxopropyl)benzimidazoles. The reduction of these transamination products with NaBH4 in methanol produced the corresponding 1-(3-hydroxypropyl)benzimidazoles in excellent yields.

  苯并咪唑，在2位被不同取代的苯并咪唑和5,6-二甲基苯并咪唑已在 N 1被衍生自苯乙酮，乙酰萘，2-乙酰基噻吩和1-四氢萘酮的酮基曼尼希碱烷基化， 从而制得一系列新型的1-（3-氧代丙基） ）苯并咪唑 在甲醇中用NaBH 4还原这些氨基转移产物可产生相应的1-（3-羟丙基）苯并咪唑类，产率很高。
• A Novel Antifungal Agent with Broad Spectrum: 1-(4-Biphenylyl)-3-(1<i>H</i>-imidazol-1-yl)-1-propanone
  作者：Gheorghe Roman、Mihai Mareş、Valentin Năstasă

  DOI：10.1002/ardp.201200287

  日期：2013.2

  carbonyl function of the imidazole–ketones in the previous series by means of NaBH4. All of the compounds were evaluated for antifungal activity against 16 strains of Candida, and 3‐(1H‐imidazol‐1‐yl)‐1‐(4‐biphenylyl)‐1‐propanone emerged as a broad‐spectrum antifungal agent. Several 3‐(1H‐imidazol‐1‐yl)‐1‐(2′‐(substituted benzyl)oxyphenyl)‐1‐propanones were also active towards Candida kefyr.

  通过咪唑与3-二甲氨基-1-（取代芳基）-1-丙酮盐酸盐的N-烷基化合成一系列（1-取代芳基）-3-（1H-咪唑-1-基）-1-丙酮（酮曼尼希碱）。第二系列 N1 取代的咪唑是通过使用 NaBH4 还原前一系列中咪唑-酮的羰基官能团而获得的。评估了所有化合物对 16 种念珠菌的抗真菌活性，3-(1H-咪唑-1-基)-1-(4-联苯基)-1-丙酮作为广谱抗真菌剂出现。几种 3-(1H-咪唑-1-基)-1-(2'-(取代苄基)氧基苯基)-1-丙酮对克菲尔念珠菌也有活性。
• Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(.omega.-phenyl-.omega.-hydroxyalkyl)imidazoles
  作者：Dante Nardi、Alberto Tajana、Amedeo Leonardi、Renzo Pennini、Ferruccio Portioli、Maria Jose Magistretti、Alessandro Subissi

  DOI：10.1021/jm00138a017

  日期：1981.6

  A novel series of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles was synthesized and evaluated for anticonvulsant activity in mice against maximal electroshock induced seizures. Some of the compounds showed an activity comparable to or better than phenytoin and phenobarbital. The N-[beta-[4-(beta-phenylethyl)phenyl]-beta-hydroxyethyl]imidazole (38) was selected for further studies; preclinical toxicology and additional efficacy evaluations are in progress. Structure-activity relationships are discussed.
• Substituent effects in the homolytic brominolysis of substituted phenylcyclopropanes
  作者：Douglas E. Applequist、Lee F. McKenzie

  DOI：10.1021/jo00875a009

  日期：1976.6
• NARDI, D.;TAJANA, A.;LEONARDI, A.;PENNINI, R.;PORTIOLI, F.;MAGISTRETTI, M+, J. MED. CHEM., 1981, 24, N 6, 727-731
  作者：NARDI, D.、TAJANA, A.、LEONARDI, A.、PENNINI, R.、PORTIOLI, F.、MAGISTRETTI, M+

  DOI：——

  日期：——